MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/eci.13746

Медицинская библиотека · European journal of clinical investigation · 2022

Case series of massive direct oral anticoagulant ingestion-Treatment and pharmacokinetics data.

Delrue Maxime, Chevillard Lucie, Stépanian Alain, Dragoni Alessandra, Camoin-Jau Laurence, Voicu Sébastien, Malissin Isabelle, Deye Nicolas, Gainnier Marc, Siguret Virginie, Mégarbane Bruno

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Direct oral anticoagulants (DOAC) are widely used due to favourable benefit/risk ratio. However, consequences of massive ingestion have been poorly investigated.

OBJECTIVES

We aimed to report outcome and pharmacokinetic parameters in patients who massively ingested DOACs.

METHODS

We conducted a 5-year cohort study including consecutive massive DOAC ingestion patients admitted to two critical care departments. Patients were managed in accordance with standards of care. We collected the main history, clinical, laboratory, management and outcome data. The time-course of plasma DOAC concentrations measured using specific assays was modelled.

RESULTS

Twelve patients (3F/9M; age, 55 years [41-63], median [25th-75th percentiles]) were included. Ingestions involved rivaroxaban (n = 7), apixaban (n = 3) and dabigatran (n = 2), with presumed doses of 9.4-fold [5.0-22.0] the full daily dose. Six patients received activated charcoal but no antidote nor blood-derived product. No bleeding was observed. One patient died due to refractory cardiogenic shock related to bisoprolol co-intoxication. Highest observed peak plasma concentrations were 1720 ng/ml (rivaroxaban), 750 ng/ml (apixaban) and 644 ng/ml (dabigatran). Times to reach DOAC concentration below 50 ng/ml were ~20-45 h (rivaroxaban), ~125 h (apixaban) and ~30-50 h (dabigatran). Elimination half-lives were 2.5-25.5 h (rivaroxaban), 22.0 and 36.5 h (apixaban), and 5.8 and 15.5 h (dabigatran), with substantial interindividual variability and prolongation in case of cardiovascular failure related to co-intoxicants. Charcoal administration, even if delayed, may have contributed to limit toxicity, possibly by reducing absorption and/or enteroenteric recycling.

CONCLUSION

No bleeding was observed in this series of massive DOAC ingestions despite elevated plasma concentrations. No patient required specific haemostatic agents. Charcoal administration should be considered to limit toxicity.

Для цитирования: Delrue Maxime, Chevillard Lucie, Stépanian Alain, Dragoni Alessandra, Camoin-Jau Laurence, Voicu Sébastien, Malissin Isabelle, Deye Nicolas, Gainnier Marc, Siguret Virginie, Mégarbane Bruno. Case series of massive direct oral anticoagulant ingestion-Treatment and pharmacokinetics data.. European journal of clinical investigation. 2022. DOI: 10.1111/eci.13746.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.